The PMHNP is seeing a patient in follow-up. The patient has a diagnosis of schizoaffective disorder and has been taking the second-generation antipsychotic olanzapine for 2 months. The patient appears to be experiencing a distinct improvement in both the positive symptoms of schizophrenia as well as depressive symptoms of major depressive disorder. The NP evaluates for which of the following common adverse drug effects of this  medication? 

A. Weight gain 

B. Insomnia 

C. Diarrhea 

D. Nausea 

---

YouTube: https://www.youtube.com/watch?v=YbhPr5zUa78&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=132



Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Fitzgerald Health Education Associates. Innehållet i podden är skapat av Fitzgerald Health Education Associates och inte av, eller tillsammans med, Poddtoppen.